News & Events

On 5 September the RSNN organized its Annual Workshop. We are looking back at a successful afternoon with great interaction, inspiring speakers and insights from various stakeholder groups (patients, industry, academia, and regulators) on the topic of patient preferences.

The RSNN interview series aims to give a better insight into the persons and organizations involved in the activities of RSNN. The series also provide an opportunity to highlight some of the current topics in the Regulatory Science field. For this fourth interview in the series, Peter Mol was interviewed.

On 2 June 2022 the RSNN hosted a parallel session during the FIGON & EUFEPS European medicines days (www.figondmd.nl) in the Stadsgehoorzaal in Leiden. The session was chaired by Sini Eskola (EFPIA) and speakers from different backgrounds were present.

Registration for the RSNN Annual workshop is now open. This year, the workshop will take place on 5 September and focus on the topic "Patient preferences: towards a more structural incorporation in the regulatory pathway".

A new edition of the RSNN Newsletter has just been published.

The Regulatory Science Network Netherlands (RSNN) is excited to announce that Marjon Pasmooij (CBG-MEB), Sjaak Bot (Janssen) and Peter Mol (UMCG) have been appointed as new chairs of RSNN. The new chairs each represent one of the three main stakeholder groups within RSNN: regulators, industry and academia.

The full report of the RSNN Annual Workshop titled "Upstream regulatory convergence & downstream divergence: unequal access for patients?" which took place on 23 November 2021 is now available.

On 15 February Carla Jonker successfully defended her PhD thesis titled “Rare disease registries: a must for regulatory decision making” at the University Hall in Utrecht.

On Tuesday January 18th, the European Medicines Agency (EMA) hosted the Regulatory Science Research Needs (RSRN) launch event. The online event was organized to inform the public and stakeholders, such as researchers and research funders, on the RSRN initiative.

On 23 November the RSNN organized its Annual Workshop. We are looking back at a successful meeting with great interaction between the participants. The hybrid setting allowed a large audience to attend in person or online. There were many learnings from the various perspectives of the speakers on the topic of upstream convergence and downstream divergence.

The RSNN expert meeting on the topic of ‘Regulatory Readiness Levels as a tool to drive regulatory innovation’ took place on 29 June 2021. Eighteen experts affiliated to academia, industry, and government bodies were invited to discuss the topic. The full report of the meeting is now available.

The RSNN interview series aims to give a better insight into the persons and organizations involved in the activities of RSNN. It also provides an opportunity to highlight some of the current topics in the Regulatory Science field. For this third interview in the series, Wieteke Wouters was interviewed.

A new edition of the RSNN Newsletter has just been published.

The RSNN expert meeting on the topic of ‘The route for Advanced Therapy Medicinal Products (ATMPs) from bench to bedside: the local hospital exemption procedure versus the EMA centralised authorisation’ was held on 10 March 2021. The full report of the meeting is now available.

Only a couple of days to go until the RSNN annual workshop 2021.